356 related articles for article (PubMed ID: 17992591)
1. Sjögren's syndrome--study of autoantigens and autoantibodies.
Routsias JG; Tzioufas AG
Clin Rev Allergy Immunol; 2007 Jun; 32(3):238-51. PubMed ID: 17992591
[TBL] [Abstract][Full Text] [Related]
2. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms.
Tzioufas AG; Tatouli IP; Moutsopoulos HM
Presse Med; 2012 Sep; 41(9 Pt 2):e451-60. PubMed ID: 22840991
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
6. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects.
Mavragani CP; Tzioufas AG; Moutsopoulos HM
Int Arch Allergy Immunol; 2000 Sep; 123(1):46-57. PubMed ID: 11014971
[TBL] [Abstract][Full Text] [Related]
8. Subgroups of Sjögren syndrome patients according to serological profiles.
Bournia VK; Vlachoyiannopoulos PG
J Autoimmun; 2012 Aug; 39(1-2):15-26. PubMed ID: 22575069
[TBL] [Abstract][Full Text] [Related]
9. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune response and target autoantigens in Sjogren's syndrome.
Routsias JG; Tzioufas AG
Eur J Clin Invest; 2010 Nov; 40(11):1026-36. PubMed ID: 20629708
[TBL] [Abstract][Full Text] [Related]
11. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic markers of Sjögren's syndrome.
Witte T
Dev Ophthalmol; 2010; 45():123-128. PubMed ID: 20502032
[TBL] [Abstract][Full Text] [Related]
13. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
Turkçapar N; Olmez U; Tutkak H; Duman M
Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
[TBL] [Abstract][Full Text] [Related]
14. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
15. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
Locht H; Pelck R; Manthorpe R
J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms.
Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
J Autoimmun; 2014 Jun; 51():67-74. PubMed ID: 24333103
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies and their target antigens in Sjögren's syndrome.
Meilof JF; Smeenk RJ
Neth J Med; 1992 Apr; 40(3-4):140-7. PubMed ID: 1603204
[TBL] [Abstract][Full Text] [Related]
19. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
20. The epitope study of alpha-fodrin autoantibody in primary Sjögren's syndrome.
Chen Q; Li X; He W; Zhang H; Gao A; Cheng Y; Lei J; Li S; Zeng L
Clin Exp Immunol; 2007 Sep; 149(3):497-503. PubMed ID: 17614976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]